
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, et al.
ERJ Open Research (2021) Vol. 7, Iss. 4, pp. 00411-2021
Open Access | Times Cited: 24
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, et al.
ERJ Open Research (2021) Vol. 7, Iss. 4, pp. 00411-2021
Open Access | Times Cited: 24
Showing 24 citing articles:
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases
Eusebi Chiner‐Vives, Rosa Cordovilla, David de la Rosa, et al.
Archivos de Bronconeumología (2022) Vol. 58, pp. 39-50
Open Access | Times Cited: 52
Eusebi Chiner‐Vives, Rosa Cordovilla, David de la Rosa, et al.
Archivos de Bronconeumología (2022) Vol. 58, pp. 39-50
Open Access | Times Cited: 52
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation
Valentino Bezzerri, Valentina Gentili, Martina Api, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Valentino Bezzerri, Valentina Gentili, Martina Api, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Success of the German Cystic Fibrosis Registry
Lutz Naehrlich, Manuel Burkhart
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access
Lutz Naehrlich, Manuel Burkhart
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access
Respiratory Infection and Inflammation in Cystic Fibrosis: A Dynamic Interplay among the Host, Microbes, and Environment for the Ages
Christiaan Yu, Tom Kotsimbos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4052-4052
Open Access | Times Cited: 12
Christiaan Yu, Tom Kotsimbos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4052-4052
Open Access | Times Cited: 12
Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review
Vito Terlizzi, Marco Antonio Motisi, Roberta Pellegrino, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 16
Vito Terlizzi, Marco Antonio Motisi, Roberta Pellegrino, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 16
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation
Francesca Lucca, Valentino Bezzerri, Elisa Danese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 908-908
Open Access | Times Cited: 9
Francesca Lucca, Valentino Bezzerri, Elisa Danese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 908-908
Open Access | Times Cited: 9
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis
Harriet Corvol, Sandra de Miranda, Clémence Dehillotte, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2135-2144
Open Access | Times Cited: 11
Harriet Corvol, Sandra de Miranda, Clémence Dehillotte, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2135-2144
Open Access | Times Cited: 11
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review
Antonio Vitiello, Michela Sabbatucci, Andrea Silenzi, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Antonio Vitiello, Michela Sabbatucci, Andrea Silenzi, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis
Leonardo Souza Marques, Matheus Negri Boschiero, Nathália Mariana Santos Sansone, et al.
Healthcare (2023) Vol. 11, Iss. 13, pp. 1936-1936
Open Access | Times Cited: 4
Leonardo Souza Marques, Matheus Negri Boschiero, Nathália Mariana Santos Sansone, et al.
Healthcare (2023) Vol. 11, Iss. 13, pp. 1936-1936
Open Access | Times Cited: 4
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2
Davide Ferrari, Michele Rubini, Jorge S. Burns
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Davide Ferrari, Michele Rubini, Jorge S. Burns
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 5
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 5
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?
Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Vaccines (2023) Vol. 11, Iss. 3, pp. 657-657
Open Access | Times Cited: 2
Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Vaccines (2023) Vol. 11, Iss. 3, pp. 657-657
Open Access | Times Cited: 2
Incidence and Severity of SARS-CoV-2 Infections in People With Primary Ciliary Dyskinesia
Eva S.L. Pedersen, Leonie D Schreck, Myrofora Goutaki, et al.
International Journal of Public Health (2023) Vol. 68
Open Access | Times Cited: 2
Eva S.L. Pedersen, Leonie D Schreck, Myrofora Goutaki, et al.
International Journal of Public Health (2023) Vol. 68
Open Access | Times Cited: 2
Long-Term Assessment of Antibody Response to COVID-19 Vaccination in People with Cystic Fibrosis and Solid Organ Transplantation
Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Vaccines (2024) Vol. 12, Iss. 1, pp. 98-98
Open Access
Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Vaccines (2024) Vol. 12, Iss. 1, pp. 98-98
Open Access
A COVID–19-fertőzéssel és -immunizációval szerzett tapasztalatok felnőtt cystás fibrosisos betegcsoportban
Zoltán Örlős, Zsuzsanna Miklós, Ildikó Horváth
Orvosi Hetilap (2024) Vol. 165, Iss. 9, pp. 332-337
Open Access
Zoltán Örlős, Zsuzsanna Miklós, Ildikó Horváth
Orvosi Hetilap (2024) Vol. 165, Iss. 9, pp. 332-337
Open Access
Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions
Fabiana Ciciriello, Francesco Panariello, Paola Medino, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 4, pp. 625-632
Closed Access
Fabiana Ciciriello, Francesco Panariello, Paola Medino, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 4, pp. 625-632
Closed Access
Occurrence of COVID-19 in cystic fibrosis patients: a review
F Abolhasani, Masood Moein, Niloofar Rezaie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
F Abolhasani, Masood Moein, Niloofar Rezaie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Clinical Outcomes Following SARS-CoV-2 Infection in Pediatric Cystic Fibrosis Patients
Andy P Huang, Andrea Espina Rey, C.G. Cherian, et al.
Cureus (2024)
Open Access
Andy P Huang, Andrea Espina Rey, C.G. Cherian, et al.
Cureus (2024)
Open Access
Multiple life-threatening complications in a patient who received lung transplantation due to cystic fibrosis and their management
Gizem Keçeci Özgür, Alı Özdıl, Pervin Korkmaz, et al.
Therapeutic Advances in Pulmonary and Critical Care Medicine (2024) Vol. 19
Closed Access
Gizem Keçeci Özgür, Alı Özdıl, Pervin Korkmaz, et al.
Therapeutic Advances in Pulmonary and Critical Care Medicine (2024) Vol. 19
Closed Access
SARS‐CoV‐2 infection in children with cystic fibrosis: A cross‐sectional multicenter study in Spain. New waves, new knowledge
Pedro Mondéjar-López, Laura Moreno‐Galarraga, Cristina de Manuel Gómez, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 11, pp. 3195-3205
Open Access
Pedro Mondéjar-López, Laura Moreno‐Galarraga, Cristina de Manuel Gómez, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 11, pp. 3195-3205
Open Access
The clinical features and impact of SARS-CoV-2/COVID-19 infection in children with Cystic Fibrosis (CF): A Qatari experience
Sara G. Hamad, H. Kammouh, Mohammed Alamri, et al.
Qatar medical journal (2023) Vol. 2023, Iss. 3
Open Access
Sara G. Hamad, H. Kammouh, Mohammed Alamri, et al.
Qatar medical journal (2023) Vol. 2023, Iss. 3
Open Access
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA
Jacob D. Bradbury, Emily Chesshyre, Annalisa Orenti, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 2, pp. 354-363
Open Access
Jacob D. Bradbury, Emily Chesshyre, Annalisa Orenti, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 2, pp. 354-363
Open Access
Incidence and severity of SARS-CoV-2 infections in people with primary ciliary dyskinesia
Eva S.L. Pedersen, Leonie D Schreck, Myrofora Goutaki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Eva S.L. Pedersen, Leonie D Schreck, Myrofora Goutaki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access